PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-21.67%
Both yoy net incomes decline, with JHX at -40.20%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-27.31%
Negative yoy D&A while JHX is 2.11%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-100.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
8.62%
SBC growth while JHX is negative at -7.32%. John Neff would see competitor possibly controlling share issuance more tightly.
223.47%
Well above JHX's 122.13% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
100.00%
AR growth is negative or stable vs. JHX's 286.93%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
-59.74%
Both reduce yoy inventory, with JHX at -51.89%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-100.00%
Both negative yoy AP, with JHX at -36.84%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
100.00%
Growth well above JHX's 152.33%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-3.21%
Negative yoy while JHX is 59.81%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
20.40%
Operating cash flow growth below 50% of JHX's 50.90%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-19.13%
Both yoy lines negative, with JHX at -3.63%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-285.45%
Both yoy lines negative, with JHX at -100.28%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
150.83%
Purchases well above JHX's 100.59%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
No Data
No Data available this quarter, please select a different quarter.
-121.19%
We reduce yoy other investing while JHX is 99.20%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-79.35%
We reduce yoy invests while JHX stands at 10.31%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
1403.85%
Debt repayment above 1.5x JHX's 80.14%, indicating stronger deleveraging. David Dodd would verify if expansions are not neglected.
No Data
No Data available this quarter, please select a different quarter.
-97.76%
We cut yoy buybacks while JHX is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.